Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ADVANTAGE SERIES CONTOURED LUMBO SACAR

K-Number: K832881 · 1983-09-26

ApplicantDepuy, Inc.
Decision Date1983-09-26
Product Code
DecisionSubstantially Equivalent

Device Summary

ADVANTAGE SERIES CONTOURED LUMBO SACAR is the device name listed in this FDA 510(k) record. The listed applicant is Depuy, Inc.. It received FDA 510(k) clearance on 1983-09-26 under 510(k) number K832881. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ADVANTAGE SERIES CONTOURED LUMBO SACAR?

ADVANTAGE SERIES CONTOURED LUMBO SACAR is a medical device that received FDA 510(k) clearance on 1983-09-26. The listed applicant is Depuy, Inc.. The 510(k) number is K832881.

When did ADVANTAGE SERIES CONTOURED LUMBO SACAR receive FDA 510(k) clearance?

ADVANTAGE SERIES CONTOURED LUMBO SACAR received FDA 510(k) clearance on 1983-09-26, under 510(k) number K832881.

Who is the listed applicant for ADVANTAGE SERIES CONTOURED LUMBO SACAR?

The FDA 510(k) record lists Depuy, Inc. as the applicant. This does not by itself establish the device manufacturer.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Depuy, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 303 devices →

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑